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Background: Ultrathin transnasal EGD is a very safe technique in common people. This study was con-
ducted to explore the safety and tolerance of ultrathin transnasal esophagogastroduodenoscopy (EGD) in
geriatric patients.
Methods: A total of 327 patients referred for diagnostic transnasal EGDwere allocated to three groups on the
basis of age: groupA (between 70 and 85 years), group B (older than 85 years), and control (younger than 70
years). Pre-EGD anxiety was measured using the 100-mm visual analog scale (VAS). After EGD, patients
were required to complete a questionnaire on pain, nausea, choking, overall discomfort, and quality of the
examination either using VAS or answering some questions. The duration of EGDwas timed. Blood pressure
(BP), oxygen saturation (SpO2), and heart rate (HR) were monitored before, during, and after EGD.
Results: There was no statistically signiﬁcant association with age, gender, baseline VAS, SpO2, BP, HR, and
duration of the procedure among all groups. Transnasal EGD was successfully completed in all patients.
No severe complication(s) occurred in all groups. Compared to baseline data, systolic BP (SBP), diastolic
BP (DBP), and HR gradually rose before endoscopy was initiated, but they decreased 5 minutes after
endoscopic insertion. However, the change in SpO2 showed a contrary trend during the whole procedure.
There was no statistical signiﬁcance with the differential value compared to the baseline of DBP, HR, and
SpO2 during the different stages between groups A, B, and control. Compared to baseline data, only SBP
during following endoscopic insertion and endoscopy in group B increased with statistical signiﬁcance.
On the basis of the patients’ evaluation, no difference was found in intubation pain, overall discomfort,
choking, nausea/vomiting, or overtolerance among the three groups.
Conclusion: Ultrathin transnasal EGD has good technical performances, has high security and reliability,
and is generally well accepted and preferred by geriatric patients.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Esophagogastroduodenoscopy (EGD) has been widely recog-
nized as a screening modality for the diagnosis of upper gastroin-
testinal disorders. However, it can evoke anxiety, feelings of
vulnerability, embarrassment, and discomfort1. The fears and
concerns associated with the endoscopic procedure decrease the
patient’s compliance, making EGD execution more difﬁcult2e4, and
in many countries EGD is performed using conscious sedation5,6.
Although usually safe, sedation is not free from adverse effects7e9
and produces a 30e50% increase of EGD-related costs, eithererest.
tment of Gastroenterology,
gzhou, Hubei 434000, China.
iwan Society of Geriatric Emergendirect (medications, additional time required to sedate and recover
the patients, additional personnel needed to monitor the patients)
or indirect (time lost from work by both the patient and patient’s
escort)10,11. Thus, it has been emphasized that any EGD should be
performed with minimal morbidity and mortality. Despite tech-
nical improvements, the complications of EGD are still of signiﬁcant
clinical relevance12, among which cardiovascular complications are
a major problem that may cause serious and occasionally lethal
damage. In fact, more than half of the serious complications of
endoscopy have been reported to occur in association with preex-
isting cardiopulmonary disorders13e15. Thus, a safe endoscopic
technique less stressful to the cardiovascular system is recom-
mendatory, particularly for patients with such disorders.
Recently, the development of ultrathin endoscopes has made it
possible to insert these devices through the nasal cavity16e21.
Several studies have demonstrated better tolerance and acceptancecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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unsedated patients16e19. Moreover, transnasal EGD has been shown
to cause fewer adverse effects on cardiovascular function than
transoral EGD20,21.
Many studies have reported that ultrathin transnasal EGD is
a very safe technique in most people16. Since an increasing
proportion of the population is reaching an advanced age, this
leads to the question: Is it equally safe to use in geriatric
patients? In order to further evaluate the yield and feasibility of
ultrathin transnasal EGD in the very old, we analyzed the indi-
cation and clinical ﬁndings in a large sample of patients aged 85
years or more. The ultimate issue here was to determine whether
ultrathin transnasal EGD is a useful and safe procedure in geri-
atric patients.
2. Materials and methods
2.1. Patients
The experiment was carried out at the department of gastro-
enterology, in the First Hospital of Yangtze University in China.
Between May 2009 and May 2010, all patients (inpatients and
outpatients) who were scheduled for transnasal EGD procedure at
our department and gave informed consent were eligible for this
prospective observational study. Patients with a known history of
severe cardiopulmonary disease were excluded. Patients between
70 and 85 years of age were assigned to group A, while those older
than 85 years were assigned to group B. The records of all patients
younger than 70 years treated during the same period served as the
control. The data of all groups are listed in Table 1. The study
protocol was approved by the local Ethics Committee for Human
Studies.
2.2. Endoscopy procedure
The Olympus GIF-XP260 N videoendoscope (Olympus Medical
Systems Corp. Tokyo, Japan) with a 5.0-mm outer diameter, an air-
water channel, a biopsy channel of 2-mm diameter, a depth of ﬁeld
of 3e100 mm, and a 110-cm working length was used. All proce-
dures were performed by senior endoscopists experienced in
transnasal EGD. All of them had previously performedmore than 10
procedures with the one-plane bending endoscope. Topical anes-
thesia of the nasal cavities was conducted by applying cotton
pledgets with a 5% lidocaine and 0.002% naphazoline solution. The
endoscope was inserted under visual control, through the more
patent nostril (or if this proves impossible, then the other one) to
the pharynx. The upper esophageal sphincter was crossed underTable 1
Demographic and clinical data of the patients.
Group A
Age, y 70e85
Number, n 131
Gender
Male, n 70
Female, n 61
Baseline anxiety score in VAS (mean SD) 45.97 31.52
Baseline oxygen saturation (%; mean SD) 98.87 1.03
Baseline heart rate (beats/min; mean SD) 83.42 12.93
Baseline SBP (mmHg; mean SD) 122.72 20.32
Baseline DBP (mmHg; mean SD) 76.33 13.98
Successful completion EGD, n (%) 131 (100%)
Duration of EGD (min; mean SD) 3.49 1.64
Complications, n (%) 2 (1.5%)
There was no statistically signiﬁcant association with age, gender, baseline VAS, SPO2,
Complications include blood oxygen desaturation and tachycardia.
DBP¼ diastolic blood pressure; EGD¼ esophagogastroduodenoscopy; HR¼ heart rate; Sdirect vision. The esophagus, the stomach, and the duodenumwere
examined as usual. Biopsies were performed only when necessary.
All endoscopies were conducted without any premedication or
sedation. A cardiovascular specialist participated during the entire
procedure to rescue the patients in cases of emergency.
2.3. Demographic and clinical data of the patients before EGD
examination
Age, gender, prior experience of endoscopic examination, blood
oxygen saturation (SpO2), blood pressure (BP), and heart rate (HR)
were recorded. Since anxiety was hypothesized to be a potential
factor of discomfort, all patients were asked to rate their pre-EGD
anxiety level using a 100-mm visual analog scale (VAS)22,23, with
100 being the highest level. The patients were also asked to specify
what they dreaded more about endoscopic examination among the
following six items: fear of pain, fear of vomiting, fear of stiﬂing,
fear of complications, fear of endoscopic ﬁndings, and others
(Table 1).
2.4. Evaluation of the quality and duration of examination
The following parameters, HR, SpO2, BP (include SBP and DBP),
were measured continuously and recorded every minute using
a multifunctional monitor. Recorded data were analyzed and
averaged over the following time intervals: baseline, at least 5
minutes before inserting the transnasal EGD; before, just before
starting endoscopy; insertion, immediately after endoscopic
insertion; endoscopy, during endoscopy 5minutes after endoscopic
insertion; post-procedure, 3 minutes after completion of endos-
copy. The duration of EGD was timed in all patients. A procedure
was considered complete if gastric retroﬂexion was accomplished,
the second portion of the duodenumwas reached, and all indicated
biopsies were obtained. The occurrence of complications was
recorded after each procedure.
2.5. Evaluation of patients’ tolerance
Data were collected from the patient after the end of the
procedure. The sensation of pain and overall discomfort were
quantiﬁed on a 100-mm VAS (0¼ nonexistent, 100¼ unbearable),
and the overall tolerance to EGD was assessed as very poor, poor,
fair, good, excellent. Patients scored their sensation of nausea and
choking on a 100-mm VAS, and also indicated their tolerance by
answering the questions, “How did you tolerate EGD, and what you
were expecting?” and choosing one of the following three items:
worse than expected, as expected, better than expected.Group B Control p
>85 <70
95 101 0.626
0.612
46 63
49 38
46.83 30.45 45.23 29.97 0.457
98.72 1.19 99.01 0.98 0.595
84.03 13.27 81.72 12.01 0.290
125.26 22.15 119.82 19.86 0.648
78.47V14.42 74.74 13.07 0.440
95 (100%) 101 (100%) 0.130
3.73 1.71 3.25 1.59 0.673
1 (1.1%) 0 (0.0%) 0.516
HR, SBP, DBP, EGD completion and duration, and complications among all groups.
BP¼ systolic blood pressure; SPO2¼ oxygen saturation; VAS¼ visual analog scale.
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Fig. 1. There was no statistical signiﬁcance in the differential value compared to the
baseline of SpO2 during the different stages (before, insertion, endoscopy, post-
procedure) among group A, group B, and control.
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Fig. 2. There was no statistical signiﬁcance in the differential value compared to the
baseline of HR during the different stages (before, insertion, endoscopy, post-
procedure) among group A, group B, and control.
Ultrathin Transnasal EGD in Geriatric Patients 2192.6. Statistical analysis
Statistical analysis was performed using SPSS 13.0 (SPSS Inc.,
Chicago, IL, USA) statistical software packages. Gender and previous
experience of endoscopic examinationwere analyzed using the chi-
square test. Age and pre-endoscopic anxiety levels were analyzed
using the KruskaleWallis nonparametric test. KruskaleWallis test
was also used to analyze the duration of EGD, difﬁculty in intro-
duction of the gastroscope, nausea, choking, and performances
of the endoscope. Repeated-measures analysis of variancewas used
to compare the patients’ opinions on intubation pain, overall
discomfort, and overall tolerance. Repeated-measures analysis of
variance was also used to test for differences between groups in BP,
HR, and SpO2 over time. Correction with post hoc tests (Bonferroni
method) was used because repeated measurements of a single
variable were tested over time. The statistical power of the sample
size was also evaluated, and levels over 90% were found in most
parts of the tests applied. A p value <0.05 was considered to be
statistically signiﬁcant.
3. Results
A total of 327 patients (include inpatients and outpatients)
underwent this procedure. They were divided into group A, group
B, and control group on the basis of their ages. Patients between 70
and 85 years old were assigned to group A (n¼ 131), while those
older than 85 years were assigned to group B (n¼ 95). The records
of all patients younger than 70 years treated during the same
period served as the control (n¼ 101). These data are summarized
in Table 1. There was no statistical signiﬁcant association with age,
gender, baseline VAS, SPO2, HR, SBP, and DBP among all groups
(p¼ 0.626, 0.612, 0.457, 0.595, 0.290, 0.648, and 0.440, respec-
tively). Transnasal EGDwas successfully completed in all patients of
the three groups. The duration of the procedure was longer in
group B than in group A and control (3.731.71 vs. 3.491.64 and
3.251.59 minutes, respectively; p¼ 0.673> 0.05), but there was
no statistical signiﬁcance.
No complication occurred in the control group. In group A, one
patient had mild and self-limiting epistaxis, and another patient
had tachycardia. One patient in group B had blood oxygen desa-
turation, and recovered with oxygen inhalation. Occurrence of
abnormal vital signs (blood oxygen desaturation and tachycardia)
was more frequent in groups A and B than in the control group, but
the difference was not statistically signiﬁcant (Table 1).
Endoscopy was completed in all patients. SpO2, HR, and BP (SBP
and DBP) were observed at different stages of the procedure
which included baseline, before, insertion, endoscopy, and post-
procedure (Figs. 1e4). In all groups, compared to baseline data,
SBP, DBP, and HR were gradually elevated from before starting
endoscopy to endoscopy. After endoscopy, they decreased, but
were slightly higher than the baseline values. However, SpO2
showed a contrary trend during the whole procedure. In all groups,
there were no signiﬁcant differences in BP and SpO2 between
baseline data and just before starting endoscopy. In addition, HR
was elevated but did not reach statistical signiﬁcance. In group B,
the increased value of SBP during following endoscopic insertion
was 22.3711.14 mmHg as against SBP in the baseline, while the
increased value in the control group was 15.018.23 mmHg. The
increased value of SBP during endoscopy was 17.78 10.33 mmHg
as against SBP in the baseline; the increased value in the control
group was 10.45 6.87 mmHg. Statistical signiﬁcance was found
in the increased value of SBP between group B and the control
group during following endoscopic insertion and endoscopy
(p¼ 0.035< 0.05, p¼ 0.047< 0.05) (Fig. 3). However, compared to
the control group, there was no signiﬁcant difference in theincreased value of SBP at post-procedure in group B. No statistical
signiﬁcant was found in the differential value compared to the
baseline of DBP, HR, and SpO2 during the different stages (before,
insertion, endoscopy, post-procedure) between group A and the
control group.
On the basis of the patients’ evaluation, no difference was found
in intubation pain, overall discomfort, choking or nausea/vomiting,
and overtolerance among the three groups (Table 2). Overall, 73.3%
of patients in the control group, 74.8% in group A, and 74.8% in
group B tolerated transnasal EGD better than expected (Table 3).
Transnasal EGD was tolerated worse than expected by 5.9%, 5.3%,
and 6.3% of patients, respectively. Frequency analysis showed no
statistically signiﬁcant trend (p¼ 0.815> 0.05) among all groups.
4. Discussion
Geriatric patients are increasing in number as a result of pop-
ulation growth and advances in modern medicine. More and more
often, EDG on ever-older patients with many diseases is becoming
on option.
EDG is an uncomfortable and stressful procedure for most
patients. Sedation is routinely used by most endoscopists in
Table 2
Patients’ evaluations.
Patients’ assessment Group A Group B Control p
Intubation (pain) 30.49 12.70 32.08 13.64 29.53 12.02 0.765
Overall discomfort 33.72 18.30 35.97 20.12 31.02 19.24 0.192
Choking 13.44 9.23 15.72 9.36 14.20 9.07 0.843
Nausea/vomiting 38.80 21.89 39.57 24.40 36.39 24.01 0.784
Overall tolerance 3.25 0.71 3.03 0.81 3.37 0.62 0.098
No difference was found in intubation pain, overall discomfort, choking or nausea/
vomiting, and overall tolerance among the three groups.
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Fig. 3. Statistical signiﬁcance was found for the increased value of SBP between group
B and the control group during following endoscopic insertion and endoscopy
(*p¼ 0.035< 0.05, p¼ 0.047< 0.05).
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effectiveness is now well documented25. The cost is difﬁcult to
accurately estimate in developed countries. Nevertheless, side
effects of medications used for sedation are well known6. Narrow-
diameter endoscopes (<6 mm) were developed in the early 1990s
with the aim of reducing patient discomfort and avoiding the cost
and risks of conscious sedation. Elderly patients represent a special
group of patients, as they usually have a higher incidence of
comorbid diseases and may be more susceptible to endoscopic
interventions. Due to the decreased physiologic reserve and asso-
ciated diseases, complications in elderly patients can be more
severe than in adult or young patients26. Moreover, in relation with
the growing trend in population demographics, the use of endos-
copy is expected to rise in this particular population segment. This
study was undertaken to further explore the effect of ultrathin
transnasal EDG in geriatric patients.
In our study, we divided all samples into three groups based on
age. The results showed that patients older than 85 years and
between 70 and 85 years could successfully complete transnasal
EGD similar to patients younger than 70 years. In the history of
transnasal EGD, there was only one case of severe complication, an50
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Fig. 4. There was no statistical signiﬁcance in the differential value compared to the
baseline of DBP during the different stages (before, insertion, endoscopy, post-
procedure) among group A, group B, and control.esophageal perforation reported by Zaman et al27. In our study, no
severe complication(s) occurred in all groups, and only three
patients older than 70 years presented with very mild complica-
tions. To minimize the bias of individual patients and cultural
expectations, both cardiovascular tolerance28 and autonomic
nervous function29 during transnasal EGD have been precisely re-
ported in prospective randomized studies. A signiﬁcantly lower
elevation of blood pressure was observed in patients undergoing
transnasal EGD compared with those undergoing oral EGD,
whereas an increase in pulse rate was slightly less in patients
undergoing the nasal procedure. Changes in peripheral blood
oxygen saturation were minimal with either procedure. As a result
of autonomic nervous function analysis, less sympathetic stimula-
tion in patients undergoing transnasal EGD was postulated to lead
to a lesser elevation of blood pressure and pulse rate. With
comparable results reported by other investigators20, less cardio-
vascular stress using transnasal EGD was suggested than using oral
EGD when compared using the same ultrathin endoscope. Mean-
while, in all groups of our study, compared to baseline data, SBP,
DBP, and HR were gradually elevated from before starting endos-
copy to endoscopy. After endoscopy, they decreased, but were
slightly higher than the baseline data. However, SpO2 showed
a contrasting trend during the whole procedure. No statistical
signiﬁcance was found in the differential value compared to the
baseline of DBP, HR, and SpO2 during the different stages (before,
insertion, endoscopy, post-procedure) between group A and the
control group. With increasing age, the elastic tissue of blood
vessels can degenerate, cardiac output can decrease, and arteriolar
vascular resistance and artery stiffness can increase. As people
age, SBP rises slowly in proportion to the rise in DBP. Meanwhile,
the ability to regulate blood pressure can decrease gradually30,31.
For these reasons, the mean value of the baseline SBP in group B
was slightly higher compared to the other groups, even though
there was no statistical signiﬁcant association with age among all
groups. Compared with the other groups, facing various external
stimuli (during endoscopy), SBP in group B, which consisted of the
oldest participants and which has the worst ability to regulate
blood pressure, increased markedly. There was a statistically
signiﬁcant increase in SBP only between group B and the control
group during following endoscopic insertion and endoscopy in
our study, but all were in a safe range. These data indicated that
transnasal EGD is a safe examination in geriatric patients as with
younger patients.Table 3
Answers to the questions, “How did you tolerate EGD, and what you were
expecting?”.
Group A Group B Control p
Worse than expected, n (%) 7 (5.3%) 6 (6.3%) 6 (5.9%) 0.815
As expect, n (%) 26 (19.8%) 20 (21.1) 21 (20.8%)
Better than expected, n (%) 98 (74.8%) 69 (74.8%) 74 (73.3%)
Frequency analysis showed no statistically signiﬁcant trend (p¼ 0.815> 0.05)
among all groups.
Ultrathin Transnasal EGD in Geriatric Patients 221Our results demonstrated that transnasal EGD caused less
discomfort and was better tolerated. Importantly, these advantages
did not decrease with age. Geriatric patients and younger patients
had the same answer on the question, “How did you tolerate EGD,
and what you were expecting?” These indicated that transnasal
EGD brought less discomfort and was a better-tolerated procedure
in geriatric patients.
In conclusion, ultrathin transnasal EGD has good technical
performances, and is safe, generally well accepted, and preferred by
geriatric patients. Because of these advantages, ultrathin transnasal
EGD could be taken as a potentially useful technique for routine
upper gastrointestinal endoscopy in the geriatric population.References
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